Dr. Gallagher has transformed the field of epigenetic regulation of immune cells in tissue regeneration and cardiovascular disease. She is an expert in the molecular pathogenesis of wound repair and has contributed substantially to our understanding of epigenetics in immune cells associated with aneurysms, sepsis and most recently, COVID-19. She demonstrates a strong commitment to surgeon-scientist career development and serves on an NIH standing study section and NIDDK advisory group. Dr. Gallagher is excellent young, diverse surgeon-scientist who bridges translational science and human disease.
Dr. Gallagher is a surgeon-scientist and international leader in the immunobiology of inflammation and tissue regeneration. Dr. Gallagher’s research has focused on the intercept between epigenetics and immune cell phenotypes in tissue regeneration and vascular disease. Her work is distinguished for its high quality and impact and has established the connection between epigenetic reprogramming of immune cells in normal and pathologic tissue repair as well as other disease states.
Since joining the faculty at the University of Michigan, Dr. Gallagher’s research has focused on vascular inflammation and the intercept between epigenetics and peripheral macrophage phenotypes in wound repair and cardiovascular disease.
Research Opportunities for Rotating Students
Potential rotation projects involve the regulation of inflammation in innate immune cells post-surgery and projects to understand how innate immune cell activity is regulated by metabolic changes.